...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of International Medical Research >Prevalence, potential risk factors and mortality rates of acute respiratory distress syndrome in Chinese patients with sepsis
【24h】

Prevalence, potential risk factors and mortality rates of acute respiratory distress syndrome in Chinese patients with sepsis

机译：中国脓毒症患者急性呼吸窘迫综合征的患病率，潜在危险因素和死亡率

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective To investigate the prevalence, risk factors and mortality rate for acute respiratory distress syndrome (ARDS) in Chinese patients with sepsis. Methods This prospective study was based on data from consecutive patients with sepsis who attended Cangzhou Central Hospital between January 2017 and May 2019 and who developed ARDS. Multivariate logistic regression was used to identify risk factors associated independently with ARDS development. Results Of the 150 sepsis patients, 41 (27%) developed ARDS. Smoking history, presence of chronic obstructive pulmonary disease (COPD), the C-reactive protein (CRP) levels and the Acute Physiology and Chronic Health Evaluation II (APACHE II) scores were associated with developing ARDS. Moreover, combination of the four factors had an even better predictive value for risk of ARDS than each factor alone. 28-day mortality was higher in sepsis patients with ARDS compared with those without ARDS. Conclusions In Chinese patients with sepsis, ARDS is relatively common and is associated with increased mortality. Smoking, COPD, CRP levels and APACHE II scores may be useful in predicting sepsis patients who may be at risk of developing ARDS.
机译：目的探讨中国败血症患者急性呼吸窘迫综合征（ARDS）的患病率，危险因素和死亡率。方法该前瞻性研究基于连续患有败血症患者的数据，以2017年1月至2019年1月和2019年5月在2019年5月和世卫组织开发的患有苍州中央医院的数据。多变量逻辑回归用于识别与ARDS开发独立相关的风险因素。 150例脓毒症患者的结果，41例（27％）开发的ARDS。吸烟病史，慢性阻塞性肺病（COPD），C反应蛋白（CRP）水平和急性生理学和慢性健康评价II（Apache II）评分的存在与显影ARDS有关。此外，四种因素的组合具有比单独的每种因素更好的ARD风险的预测值。与没有ARDS的人相比，脓毒症患者28天死亡率较高。在中国败血症患者中的结论，ARDS相对普遍，与死亡率增加有关。吸烟，COPD，CRP水平和Apache II评分可用于预测可能面临疾病风险的败血症患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号